BioSpace News Archive

Merck’s Keytruda Fails in Late-Stage HCC Trial

Keytruda failed to show a statistical significance in overall survival and progression free survival in the Phase III trial.

February 20, 2019

·

2 min read

·

Alex Keown

Policy

Research Shows Many Patients Were Improperly Prescribed Fentanyl

The study found that the majority of patients who were given the powerful painkiller did not have cancer or pain associated with the disease, which is what the drug is indicated to help.

February 20, 2019

·

2 min read

·

Alex Keown

Job Trends

Seattle Area Life Science Employment Rebounds After Some Big Departures

Since Amgen shut down its Bothell, Wash. site in 2014, life science employment growth has increased 13 percent across the state. According to The Seattle Times, companies across the region are in a scaling up process.

February 20, 2019

·

3 min read

·

Alex Keown

Medtronic Announces Cash Tender Offer for Certain Outstanding Debt Securities Issued by Medtronic, Inc. and Covidien International Finance S.A.

Medtronic plc announced the commencement of a cash tender offer by its indirectly wholly owned subsidiaries

February 20, 2019

·

12 min read

Deals

Invitation to Presentation of Promore Pharma’s Year-end report for 2018

Promore Pharma AB (publ) publishes its Year-end report for 2018 at 09.00 CET on 26 February 2019

February 20, 2019

·

1 min read

Medtronic Intercept(TM) patient programmer

Medtronic Announces U.S. Commercial Launch of Deep Brain Stimulation for Medically-Refractory Epilepsy

With Official Launch and First Implant, Several Health Insurers Now Consider

February 20, 2019

·

5 min read

Policy

SD Mines Hosts Student Research Opportunities

Undergraduate students from around the country will get real-world research experience this summer while participating in Research Experience for Undergraduates programs and other research opportunities on the campus of South Dakota School of Mines & Technology.

February 20, 2019

·

3 min read

Drug Development

FDA Places Partial Clinical Hold on Xencor Clinical Trial Following Two Patient Deaths

The patients were part of a trial assessing Xencor’s mAb14045, a CD123 x CD3 bispecific antibody molecule being evaluated in patients with relapsed or refractory acute myeloid leukemia.

February 20, 2019

·

2 min read

·

Alex Keown

Job Trends

Study finds melanoma brain metastases are immunosuppressive with treatment-resistant metabolism

Research shows deadly tumors may be vulnerable to drugs that block their energy supply

February 20, 2019

·

7 min read

Business

Medtronic EVP & RTG President Geoff Martha to Speak at Leerink Partners Global Healthcare Conference

Medtronic plc, the global leader in medical technology, announced it will participate in the 8th Annual Leerink Partners Global Healthcare Conference in New York.

February 20, 2019

·

1 min read